Chimeric interleukin-6 soluble receptor/ligand proteins
US7198781B1 · kind B1 · utility
7Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 9, 1998 |
| Grant date | Apr 3, 2007 |
| Priority date | — |
| Expiry date | Jul 9, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/95
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Chimeric proteins constructed from the fusion of the naturally occurring form of the soluble IL-6 receptor and IL-6 which are useful for treatment of cancer and liver disorders, enhancement of bone marrow transplantation, and treatment of other IL-6 related conditions are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.